These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

847 related items for PubMed ID: 9494858

  • 1. Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.
    Russell RI.
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):465-9. PubMed ID: 9494858
    [Abstract] [Full Text] [Related]

  • 2. Helicobacter pylori infection and the use of NSAIDs.
    Bazzoli F, De Luca L, Graham DY.
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
    Vergara M, Catalán M, Gisbert JP, Calvet X.
    Aliment Pharmacol Ther; 2005 Jun 15; 21(12):1411-8. PubMed ID: 15948807
    [Abstract] [Full Text] [Related]

  • 7. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T, Konturek PC, Sliwowski Z, Kwiecień S, Drozdowicz D, Pawlik M, Mach K, Konturek SJ, Pawlik WW.
    J Physiol Pharmacol; 2006 Sep 15; 57 Suppl 3():67-79. PubMed ID: 17033106
    [Abstract] [Full Text] [Related]

  • 8. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B, Xia HH, Ma CW, Wong KW, Fung FM, Hui CK, Chan CK, Chan AO, Lai KC, Yuen MF, Wong BC.
    Aliment Pharmacol Ther; 2005 Aug 01; 22(3):243-9. PubMed ID: 16091062
    [Abstract] [Full Text] [Related]

  • 9. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S, Ittel TH, Wietholtz H.
    Z Gastroenterol; 2003 Aug 01; 41(8):719-28. PubMed ID: 12910426
    [Abstract] [Full Text] [Related]

  • 10. Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.
    Russell RI.
    Ital J Gastroenterol Hepatol; 1999 Aug 01; 31 Suppl 1():S14-8. PubMed ID: 10379464
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
    Arroyo MT, Forne M, de Argila CM, Feu F, Arenas J, de la Vega J, Garrigues V, Mora F, Castro M, Bujanda L, Cosme A, Castiella A, Gisbert JP, Hervas A, Lanas A.
    Helicobacter; 2004 Jun 01; 9(3):249-54. PubMed ID: 15165261
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Audit of the change of outcome of peptic ulcer disease following treatment of Helicobacter pylori.
    Jost C, Marbet UA.
    Schweiz Med Wochenschr; 1998 Jan 17; 128(3):64-71. PubMed ID: 9498257
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.